Article
A Novel Germline Heterozygous BCL11B Variant Causing Severe Atopic Disease and Immune Dysregulation.
Frontiers in immunology - 1 Jan 2021
Lu Henry Y, Sertori Robert, Contreras Alejandra V, Hamer Mark, Messing Melina, Del Bel Kate L, Lopez-Rangel Elena, Chan Edmond S, Rehmus Wingfield, Milner Joshua D, McNagny Kelly M, Lehman Anna, Wiest David L, Turvey Stuart E
Abstract excerpt
B-cell lymphoma/leukemia 11B (BCL11B) is a C2H2 zinc finger transcription factor that is critically important for regulating the development and function of a variety of systems including the central nervous system, the skin, and the immune system. Germline heterozygous variants are associated with a spectrum of clinical disorders, including severe combined immunodeficiency as well as neurological, craniofacial,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
